262 related articles for article (PubMed ID: 17379261)
1. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
Osinde M; Mullershausen F; Dev KK
Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
[TBL] [Abstract][Full Text] [Related]
4. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions.
Van Doorn R; Van Horssen J; Verzijl D; Witte M; Ronken E; Van Het Hof B; Lakeman K; Dijkstra CD; Van Der Valk P; Reijerkerk A; Alewijnse AE; Peters SL; De Vries HE
Glia; 2010 Sep; 58(12):1465-76. PubMed ID: 20648639
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes.
Yu N; Lariosa-Willingham KD; Lin FF; Webb M; Rao TS
Glia; 2004 Jan; 45(1):17-27. PubMed ID: 14648542
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.
Yamashita H; Kitayama J; Shida D; Yamaguchi H; Mori K; Osada M; Aoki S; Yatomi Y; Takuwa Y; Nagawa H
J Surg Res; 2006 Jan; 130(1):80-7. PubMed ID: 16183075
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate.
Sensken SC; Stäubert C; Keul P; Levkau B; Schöneberg T; Gräler MH
Cell Signal; 2008 Jun; 20(6):1125-33. PubMed ID: 18313900
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells.
Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM
J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation.
Sato C; Iwasaki T; Kitano S; Tsunemi S; Sano H
Biochem Biophys Res Commun; 2012 Jun; 423(1):200-5. PubMed ID: 22659743
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
Kohno T; Igarashi Y
Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells.
Nodai A; Machida T; Izumi S; Hamaya Y; Kohno T; Igarashi Y; Iizuka K; Minami M; Hirafuji M
Life Sci; 2007 Apr; 80(19):1768-76. PubMed ID: 17382352
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor phosphorylation through the S1P3 receptor subtype.
Kim DS; Park SH; Jeong YM; Kwon SB; Miller AJ; Fisher DE; Park KC
J Pharm Pharmacol; 2011 Mar; 63(3):409-16. PubMed ID: 21749389
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
Brinkmann V
Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
[TBL] [Abstract][Full Text] [Related]
16. S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
Rouach N; Pébay A; Même W; Cordier J; Ezan P; Etienne E; Giaume C; Tencé M
Eur J Neurosci; 2006 Mar; 23(6):1453-64. PubMed ID: 16553609
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation.
Kim MK; Lee HY; Kwak JY; Park JI; Yun J; Bae YS
Biochem Biophys Res Commun; 2006 Jun; 345(1):67-73. PubMed ID: 16674917
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.
Murakami A; Takasugi H; Ohnuma S; Koide Y; Sakurai A; Takeda S; Hasegawa T; Sasamori J; Konno T; Hayashi K; Watanabe Y; Mori K; Sato Y; Takahashi A; Mochizuki N; Takakura N
Mol Pharmacol; 2010 Apr; 77(4):704-13. PubMed ID: 20097776
[TBL] [Abstract][Full Text] [Related]
20. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
Lee CW; Choi JW; Chun J
Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]